| Followers | 842 |
| Posts | 122793 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Sunday, April 14, 2013 8:15:39 PM
[Updated for Form-4 filings through 3/18/13.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 592,314 1,052,000
*G Venkataraman (SVP/R&D) 426,069 229,803
*John Bishop (SVP/Pharma) 101,454 174,530
*Richard Shea (CFO) 150,854 273,650
*Bruce Leicher (Gen Cnsl) 110,249 218,228
*James Roach (CMO) 88,167 270,411
Directors
John Clarke 69,123 161,500
Bruce Downey 0 80,500
Marsha Fanucci 9,000 123,100
Peter Hutt 5,365 166,500
Thomas Koestler 0 47,750
*Bennett Shapiro 7,000 140,700
*Elizabeth Stoner 11,143 89,701
James Sulat 10,000 85,500
======================== ========= =========
All fourteen insiders 1,580,698 3,113,603
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
